Inovio Pharmaceuticals Kicks Off Phase 1 Clinical Trial for Experimental COVID-19 VaccineThe Motley Fool • 04/06/20
Inovio Pharmaceuticals plans first dosing of patients in trial of DNA COVID-19 vaccine candiate on MondayMarket Watch • 04/06/20
Inovio Pharmaceuticals Gets Help From Ology Bioservices and the Defense Department with Its COVID-19 Vaccine CandidateThe Motley Fool • 03/24/20
Inovio and Ology Bioservices awarded $11.9 million contract from DoD to work on COVID-19 vaccineMarket Watch • 03/24/20